Scholarlink

Purpose <p>Antimicrobial-resistant bacterial infections, including methicillin-resistant Staphylococcus aureus (MRSA), have a long-term negative impact on wound healing. To combat the rising problem of bacterial resistance to conventional antibiotics, several antimicrobial nanoparticles have been developed. This study aimed to formulate lipid-based bilosomes loaded with two plant-derived antimicrobial drugs; thymol (Thy) and Glycyrrhetinic acid (GA).</p> Methods <p>The synergistic efficiency of both drugs in healing MRSA-infected skin wounds was characterized in-vitro, ex-vivo, and in-vivo. A factorial experimental design was generated to investigate the effects of surfactant-to-cholesterol ratio, and the amount of bile salt on particle size and polydispersity index.</p> Results <p>The optimized bilosomal formulation containing the least amount of bile salt and span 20 showed small particle size (209.4&#xa0;nm), and high entrapment efficiency (81.2% and 90 % for GA and Thy, respectively). An early burst release effect was found, essential for providing a rapid therapeutic response at the lowest effective dose. This was followed by a controlled drug release over 24&#xa0;h. In ex-vivo rat skin, GA and Thy-loaded bilosomal gel showed the maximum skin deposition (65.2% and 71.68%, respectively). The combination of GA/Thy-loaded bilosomes caused a significant increase in killing MRSA. In-vivo efficacy on MRSA-infected wound excision mice model gave similar results where GA/Thy loaded bilosmes caused the most significant decrease in bacterial count and best wound healing results.</p> Conclusion <p>Bilosomes are potential lipid-based nanosystems for topical GA and Thy delivery due to their high skin penetration, antibacterial, and wound healing properties in the treatment of multidrug-resistant wound infections.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Bilosomal delivery of thymol-glycyrrhetinic acid: a multifaceted strategy to combat multidrug-resistant wound infections

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月14日

查看全文
  • Mohamed H. Zohdy,
  • Amal H. El-Kamel,
  • Mustafa Alseqely,
  • Basant A. Bakr,
  • Lamia A. Heikal

摘要

Purpose

Antimicrobial-resistant bacterial infections, including methicillin-resistant Staphylococcus aureus (MRSA), have a long-term negative impact on wound healing. To combat the rising problem of bacterial resistance to conventional antibiotics, several antimicrobial nanoparticles have been developed. This study aimed to formulate lipid-based bilosomes loaded with two plant-derived antimicrobial drugs; thymol (Thy) and Glycyrrhetinic acid (GA).

Methods

The synergistic efficiency of both drugs in healing MRSA-infected skin wounds was characterized in-vitro, ex-vivo, and in-vivo. A factorial experimental design was generated to investigate the effects of surfactant-to-cholesterol ratio, and the amount of bile salt on particle size and polydispersity index.

Results

The optimized bilosomal formulation containing the least amount of bile salt and span 20 showed small particle size (209.4 nm), and high entrapment efficiency (81.2% and 90 % for GA and Thy, respectively). An early burst release effect was found, essential for providing a rapid therapeutic response at the lowest effective dose. This was followed by a controlled drug release over 24 h. In ex-vivo rat skin, GA and Thy-loaded bilosomal gel showed the maximum skin deposition (65.2% and 71.68%, respectively). The combination of GA/Thy-loaded bilosomes caused a significant increase in killing MRSA. In-vivo efficacy on MRSA-infected wound excision mice model gave similar results where GA/Thy loaded bilosmes caused the most significant decrease in bacterial count and best wound healing results.

Conclusion

Bilosomes are potential lipid-based nanosystems for topical GA and Thy delivery due to their high skin penetration, antibacterial, and wound healing properties in the treatment of multidrug-resistant wound infections.